MedTrace Logo

The Effect of Plant Sterols on the Blood Lipid Profile of Subjects With and at High Risk of Type 2 Diabetes Mellitus

NCT02288585 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2017-01-19

No results posted yet for this study

Summary

Double-blind, randomised, placebo-controlled, parallel group study with two intervention arms. The study will be conducted in 150 subjects and the primary objective is to show a fasting LDL-cholesterol and triglyceride lowering effect of plant sterols in subjects with established type 2 diabetes mellitus and subjects at high risk of developing type 2 diabetes.

Conditions

Interventions

DIETARY_SUPPLEMENT

Plant sterols

Plant sterols

DIETARY_SUPPLEMENT

Placebo product

Placebo product

Sponsors & Collaborators

  • Commonwealth Scientific and Industrial Research Organisation, Australia

    collaborator OTHER_GOV

  • Unilever R&D

    lead INDUSTRY

Principal Investigators

  • Manny Noakes · Commonwealth Scientific and Industrial Research Organisation, Australia

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02288585 on ClinicalTrials.gov